Beth Lara Mapow DO (She/Her)
Cytopathology, Anatomic Pathology, Clinical Pathology
Vice Chief, Pathology & Laboratory Medicine Jefferson Health New Jersey
Join to View Full Profile
Cherry hill hospitalCherry Hill, NJ 08002
Dr. Mapow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Beth Mapow is a pathologist in New Jersey and is affiliated with multiple hospitals in the area, including Jefferson Washington Township Hospital, Jefferson Stratford Hospital, and Jefferson Cherry Hill Hospital. She received her medical degree from University of Pikeville Kentucky College of Osteopathic Medicine and has been in practice 15 years. She specializes in cytopathology, anatomic pathology, and clinical pathology.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cytopathology, 2006 - 2007- Drexel University College of Medicine/Hahnemann University HospitalResidency, Pathology-Anatomic and Clinical, 2002 - 2006
University of Pikeville Kentucky College of Osteopathic MedicineClass of 2002
Certifications & Licensure
PA State License 2008 - 2026
NJ State License 2007 - 2025
DE State License 2006 - 2009
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 5 citationsCoexistence of urogenital malformations in a female fetus with de novo 15q24 microdeletion and a literature review.Yaobin Liu, Beth Mapow
Molecular Genetics & Genomic Medicine. 2020-05-13 - 3 citationsSlippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal TumorsMarian Khalili, Hao Zhou, Anusha Thadi, Lynsey Daniels, Zhiyuan Fan
Annals of Surgical Oncology. 2020-01-01 - 3 citationsCase report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-upLynsey Daniels, Marian Khalili, William F. Morano, Michaela N. Simoncini, Beth Mapow
World Journal of Surgical Oncology. 2019-12-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
